In a retrospective study of more than 132,000 VA patients with type 2 diabetes, researchers found patients taking either metformin or thiazolidinediones had a lower risk of having colorectal polyps. Other medications, including aspirin and non-steroidal anti-inflammatory drugs, were associated with a lower risk of polypectomy.
The researchers also found risk factors for developing polyps in type 2 diabetes patients were increasing age, male gender, non-Hispanic white race and smoking, according to the news report.
Read the news report about insulin sensitizers and colon polyps.
Read other coverage about colorectal cancer:
– Two Samples in FIT Testing Improves Diagnostic Yield Without Affecting Attendance
– Interactive Voice Response System Just as Effective as Nurse Call for Endoscopy Completion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.